Format

Send to

Choose Destination
Head Neck Oncol. 2011 Mar 22;3:17. doi: 10.1186/1758-3284-3-17.

Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule.

Author information

1
Endocrinology Division, Department of Internal Medicine, University of Campinas, São Paulo, Brazil. fredfrm@fcm.unicamp.br

Abstract

BACKGROUND:

This study aimed to evaluate clinical, laboratory, ultrasound (US) and scintigraphyc parameters in thyroid nodule and to develop an auxiliary model for clinical application in the diagnosis of malignancy.

METHODS:

We assessed 143 patients who were surgically treated at a single center, 65% (93) benign vs. 35% (50) malignant lesions at final histology (1998-2008). The clinical, laboratory, scintigraphyc and US features were compared and a prediction model was designed after the multivariate analysis.

RESULTS:

There were no differences in gender, serum TSH and FT4 levels, thyroid auto-antibodies (TAb), thyroid dysfunction and scintigraphyc results (P=0.33) between benign and malignant nodule groups. The sonographic study showed differences when the presence of suspected characteristics was found in the nodules of the malignant lesions group, such as: microcalcifications, central flow, border irregularity and hypoechogenicity. After the multivariate analysis the model obtained showed age (>39 years), border irregularity, microcalcifications and nodule size over 2 cm as predictive factors of malignancy, featuring 81.7% of accuracy.

CONCLUSIONS:

This study confirmed a significant increase of risk for malignancy in patients of over 39 years and with suspicious features at US.

PMID:
21426548
PMCID:
PMC3073950
DOI:
10.1186/1758-3284-3-17
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center